Jiangsu Hengrui Medicine
600276.SS
#494
Rank
โ‚น3.448 T
Marketcap
โ‚น540.62
Share price
-0.62%
Change (1 day)
4.22%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚น588.02 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are โ‚น588.02 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31โ‚น508.18 B10.8%
2021-12-31โ‚น458.66 B17.78%
2020-12-31โ‚น389.42 B38.44%
2019-12-31โ‚น281.30 B22.9%
2018-12-31โ‚น228.88 B29.28%
2017-12-31โ‚น177.04 B26.25%
2016-12-31โ‚น140.23 B18.97%
2015-12-31โ‚น117.88 B26.74%
2014-12-31โ‚น93.00 B26.18%
2013-12-31โ‚น73.70 B42.44%
2012-12-31โ‚น51.74 B27.6%
2011-12-31โ‚น40.55 B53.61%
2010-12-31โ‚น26.39 B29.59%
2009-12-31โ‚น20.37 B28.09%
2008-12-31โ‚น15.90 B43.64%
2007-12-31โ‚น11.07 B32.89%
2006-12-31โ‚น8.33 B16.23%
2005-12-31โ‚น7.16 B8.99%
2004-12-31โ‚น6.57 B-17.68%
2003-12-31โ‚น7.98 B14.48%
2002-12-31โ‚น6.97 B6.98%
2001-12-31โ‚น6.52 B